Factor VIII inhibitors development following introduction of B‐domain‐deleted recombinant factor VIII in four hemophilia A previously treated patients

Saved in:
Bibliographic Details
Published inJournal of thrombosis and haemostasis Vol. 1; no. 11; pp. 2445 - 2446
Main Authors Roussel‐Robert, V., Torchet, M. F., Legrand, F., Rothschild, C., Stieltjes, N.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Inc 01.11.2003
Subjects
Adult
Aged
Antibody Formation
Factor VIII - immunology
Factor VIII - therapeutic use
Hemophilia A - drug therapy
Hemophilia A - immunology
Humans
Isoantibodies - blood
Middle Aged
Peptide Fragments - immunology
Peptide Fragments - therapeutic use
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1538-7933
1538-7836
1538-7836
DOI:10.1046/j.1538-7836.2003.00468.x